Product Code:571664
Published Date: Jan 03,2023
Pages: 99
Region: Global
Category: Medical Devices & Consumables
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
Transmucosal drug delivery devices are commonly used to deliver drugs locally through the mucous membrane. LPI (LP Information)' newest research report, the “Transmucosal Drug Delivery Devices Industry Forecast” looks at past sales and reviews total world Transmucosal Drug Delivery Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Transmucosal Drug Delivery Devices sales for 2023 through 2029. With Transmucosal Drug Delivery Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transmucosal Drug Delivery Devices industry. This Insight Report provides a comprehensive analysis of the global Transmucosal Drug Delivery Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transmucosal Drug Delivery Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Transmucosal Drug Delivery Devices market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transmucosal Drug Delivery Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transmucosal Drug Delivery Devices. The global Transmucosal Drug Delivery Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Transmucosal Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China market for Transmucosal Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Europe market for Transmucosal Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Global key Transmucosal Drug Delivery Devices players cover Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aegis Therapeutics LLC, Bespak Europe Ltd and Callitas Therapeutics Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022. This report presents a comprehensive overview, market shares, and growth opportunities of Transmucosal Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type Buccal Route Rectal Route Nasal Route Segmentation by application Hospital Residential This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Allergan Amphastar Pharmaceuticals Inc Aquestive Therapeutics Inc ARS Pharmaceuticals Combinent BioMedical Systems Inc Aegis Therapeutics LLC Bespak Europe Ltd Callitas Therapeutics Inc Key Questions Addressed in this Report What is the 10-year outlook for the global Transmucosal Drug Delivery Devices market? What factors are driving Transmucosal Drug Delivery Devices market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Transmucosal Drug Delivery Devices market opportunities vary by end market size? How does Transmucosal Drug Delivery Devices break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transmucosal Drug Delivery Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Transmucosal Drug Delivery Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Transmucosal Drug Delivery Devices by Country/Region, 2018, 2022 & 2029
2.2 Transmucosal Drug Delivery Devices Segment by Type
2.2.1 Buccal Route
2.2.2 Rectal Route
2.2.3 Nasal Route
2.3 Transmucosal Drug Delivery Devices Sales by Type
2.3.1 Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Transmucosal Drug Delivery Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Transmucosal Drug Delivery Devices Sale Price by Type (2018-2023)
2.4 Transmucosal Drug Delivery Devices Segment by Application
2.4.1 Hospital
2.4.2 Residential
2.5 Transmucosal Drug Delivery Devices Sales by Application
2.5.1 Global Transmucosal Drug Delivery Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Transmucosal Drug Delivery Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Transmucosal Drug Delivery Devices Sale Price by Application (2018-2023)
3 Global Transmucosal Drug Delivery Devices by Company
3.1 Global Transmucosal Drug Delivery Devices Breakdown Data by Company
3.1.1 Global Transmucosal Drug Delivery Devices Annual Sales by Company (2018-2023)
3.1.2 Global Transmucosal Drug Delivery Devices Sales Market Share by Company (2018-2023)
3.2 Global Transmucosal Drug Delivery Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Transmucosal Drug Delivery Devices Revenue by Company (2018-2023)
3.2.2 Global Transmucosal Drug Delivery Devices Revenue Market Share by Company (2018-2023)
3.3 Global Transmucosal Drug Delivery Devices Sale Price by Company
3.4 Key Manufacturers Transmucosal Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transmucosal Drug Delivery Devices Product Location Distribution
3.4.2 Players Transmucosal Drug Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Transmucosal Drug Delivery Devices by Geographic Region
4.1 World Historic Transmucosal Drug Delivery Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Transmucosal Drug Delivery Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Transmucosal Drug Delivery Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Transmucosal Drug Delivery Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Transmucosal Drug Delivery Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Transmucosal Drug Delivery Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Transmucosal Drug Delivery Devices Sales Growth
4.4 APAC Transmucosal Drug Delivery Devices Sales Growth
4.5 Europe Transmucosal Drug Delivery Devices Sales Growth
4.6 Middle East & Africa Transmucosal Drug Delivery Devices Sales Growth
5 Americas
5.1 Americas Transmucosal Drug Delivery Devices Sales by Country
5.1.1 Americas Transmucosal Drug Delivery Devices Sales by Country (2018-2023)
5.1.2 Americas Transmucosal Drug Delivery Devices Revenue by Country (2018-2023)
5.2 Americas Transmucosal Drug Delivery Devices Sales by Type
5.3 Americas Transmucosal Drug Delivery Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transmucosal Drug Delivery Devices Sales by Region
6.1.1 APAC Transmucosal Drug Delivery Devices Sales by Region (2018-2023)
6.1.2 APAC Transmucosal Drug Delivery Devices Revenue by Region (2018-2023)
6.2 APAC Transmucosal Drug Delivery Devices Sales by Type
6.3 APAC Transmucosal Drug Delivery Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transmucosal Drug Delivery Devices by Country
7.1.1 Europe Transmucosal Drug Delivery Devices Sales by Country (2018-2023)
7.1.2 Europe Transmucosal Drug Delivery Devices Revenue by Country (2018-2023)
7.2 Europe Transmucosal Drug Delivery Devices Sales by Type
7.3 Europe Transmucosal Drug Delivery Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transmucosal Drug Delivery Devices by Country
8.1.1 Middle East & Africa Transmucosal Drug Delivery Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Transmucosal Drug Delivery Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Transmucosal Drug Delivery Devices Sales by Type
8.3 Middle East & Africa Transmucosal Drug Delivery Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transmucosal Drug Delivery Devices
10.3 Manufacturing Process Analysis of Transmucosal Drug Delivery Devices
10.4 Industry Chain Structure of Transmucosal Drug Delivery Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transmucosal Drug Delivery Devices Distributors
11.3 Transmucosal Drug Delivery Devices Customer
12 World Forecast Review for Transmucosal Drug Delivery Devices by Geographic Region
12.1 Global Transmucosal Drug Delivery Devices Market Size Forecast by Region
12.1.1 Global Transmucosal Drug Delivery Devices Forecast by Region (2024-2029)
12.1.2 Global Transmucosal Drug Delivery Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transmucosal Drug Delivery Devices Forecast by Type
12.7 Global Transmucosal Drug Delivery Devices Forecast by Application
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Transmucosal Drug Delivery Devices Product Portfolios and Specifications
13.1.3 Allergan Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Amphastar Pharmaceuticals Inc
13.2.1 Amphastar Pharmaceuticals Inc Company Information
13.2.2 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product Portfolios and Specifications
13.2.3 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Amphastar Pharmaceuticals Inc Main Business Overview
13.2.5 Amphastar Pharmaceuticals Inc Latest Developments
13.3 Aquestive Therapeutics Inc
13.3.1 Aquestive Therapeutics Inc Company Information
13.3.2 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product Portfolios and Specifications
13.3.3 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aquestive Therapeutics Inc Main Business Overview
13.3.5 Aquestive Therapeutics Inc Latest Developments
13.4 ARS Pharmaceuticals
13.4.1 ARS Pharmaceuticals Company Information
13.4.2 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product Portfolios and Specifications
13.4.3 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 ARS Pharmaceuticals Main Business Overview
13.4.5 ARS Pharmaceuticals Latest Developments
13.5 Combinent BioMedical Systems Inc
13.5.1 Combinent BioMedical Systems Inc Company Information
13.5.2 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product Portfolios and Specifications
13.5.3 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Combinent BioMedical Systems Inc Main Business Overview
13.5.5 Combinent BioMedical Systems Inc Latest Developments
13.6 Aegis Therapeutics LLC
13.6.1 Aegis Therapeutics LLC Company Information
13.6.2 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product Portfolios and Specifications
13.6.3 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aegis Therapeutics LLC Main Business Overview
13.6.5 Aegis Therapeutics LLC Latest Developments
13.7 Bespak Europe Ltd
13.7.1 Bespak Europe Ltd Company Information
13.7.2 Bespak Europe Ltd Transmucosal Drug Delivery Devices Product Portfolios and Specifications
13.7.3 Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bespak Europe Ltd Main Business Overview
13.7.5 Bespak Europe Ltd Latest Developments
13.8 Callitas Therapeutics Inc
13.8.1 Callitas Therapeutics Inc Company Information
13.8.2 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product Portfolios and Specifications
13.8.3 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Callitas Therapeutics Inc Main Business Overview
13.8.5 Callitas Therapeutics Inc Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Transmucosal Drug Delivery Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Transmucosal Drug Delivery Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Buccal Route Table 4. Major Players of Rectal Route Table 5. Major Players of Nasal Route Table 6. Global Transmucosal Drug Delivery Devices Sales by Type (2018-2023) & (K Units) Table 7. Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2018-2023) Table 8. Global Transmucosal Drug Delivery Devices Revenue by Type (2018-2023) & ($ million) Table 9. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2018-2023) Table 10. Global Transmucosal Drug Delivery Devices Sale Price by Type (2018-2023) & (USD/Unit) Table 11. Global Transmucosal Drug Delivery Devices Sales by Application (2018-2023) & (K Units) Table 12. Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2018-2023) Table 13. Global Transmucosal Drug Delivery Devices Revenue by Application (2018-2023) Table 14. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2018-2023) Table 15. Global Transmucosal Drug Delivery Devices Sale Price by Application (2018-2023) & (USD/Unit) Table 16. Global Transmucosal Drug Delivery Devices Sales by Company (2018-2023) & (K Units) Table 17. Global Transmucosal Drug Delivery Devices Sales Market Share by Company (2018-2023) Table 18. Global Transmucosal Drug Delivery Devices Revenue by Company (2018-2023) ($ Millions) Table 19. Global Transmucosal Drug Delivery Devices Revenue Market Share by Company (2018-2023) Table 20. Global Transmucosal Drug Delivery Devices Sale Price by Company (2018-2023) & (USD/Unit) Table 21. Key Manufacturers Transmucosal Drug Delivery Devices Producing Area Distribution and Sales Area Table 22. Players Transmucosal Drug Delivery Devices Products Offered Table 23. Transmucosal Drug Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Transmucosal Drug Delivery Devices Sales by Geographic Region (2018-2023) & (K Units) Table 27. Global Transmucosal Drug Delivery Devices Sales Market Share Geographic Region (2018-2023) Table 28. Global Transmucosal Drug Delivery Devices Revenue by Geographic Region (2018-2023) & ($ millions) Table 29. Global Transmucosal Drug Delivery Devices Revenue Market Share by Geographic Region (2018-2023) Table 30. Global Transmucosal Drug Delivery Devices Sales by Country/Region (2018-2023) & (K Units) Table 31. Global Transmucosal Drug Delivery Devices Sales Market Share by Country/Region (2018-2023) Table 32. Global Transmucosal Drug Delivery Devices Revenue by Country/Region (2018-2023) & ($ millions) Table 33. Global Transmucosal Drug Delivery Devices Revenue Market Share by Country/Region (2018-2023) Table 34. Americas Transmucosal Drug Delivery Devices Sales by Country (2018-2023) & (K Units) Table 35. Americas Transmucosal Drug Delivery Devices Sales Market Share by Country (2018-2023) Table 36. Americas Transmucosal Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions) Table 37. Americas Transmucosal Drug Delivery Devices Revenue Market Share by Country (2018-2023) Table 38. Americas Transmucosal Drug Delivery Devices Sales by Type (2018-2023) & (K Units) Table 39. Americas Transmucosal Drug Delivery Devices Sales by Application (2018-2023) & (K Units) Table 40. APAC Transmucosal Drug Delivery Devices Sales by Region (2018-2023) & (K Units) Table 41. APAC Transmucosal Drug Delivery Devices Sales Market Share by Region (2018-2023) Table 42. APAC Transmucosal Drug Delivery Devices Revenue by Region (2018-2023) & ($ Millions) Table 43. APAC Transmucosal Drug Delivery Devices Revenue Market Share by Region (2018-2023) Table 44. APAC Transmucosal Drug Delivery Devices Sales by Type (2018-2023) & (K Units) Table 45. APAC Transmucosal Drug Delivery Devices Sales by Application (2018-2023) & (K Units) Table 46. Europe Transmucosal Drug Delivery Devices Sales by Country (2018-2023) & (K Units) Table 47. Europe Transmucosal Drug Delivery Devices Sales Market Share by Country (2018-2023) Table 48. Europe Transmucosal Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions) Table 49. Europe Transmucosal Drug Delivery Devices Revenue Market Share by Country (2018-2023) Table 50. Europe Transmucosal Drug Delivery Devices Sales by Type (2018-2023) & (K Units) Table 51. Europe Transmucosal Drug Delivery Devices Sales by Application (2018-2023) & (K Units) Table 52. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Country (2018-2023) & (K Units) Table 53. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Country (2018-2023) Table 54. Middle East & Africa Transmucosal Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions) Table 55. Middle East & Africa Transmucosal Drug Delivery Devices Revenue Market Share by Country (2018-2023) Table 56. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Type (2018-2023) & (K Units) Table 57. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Application (2018-2023) & (K Units) Table 58. Key Market Drivers & Growth Opportunities of Transmucosal Drug Delivery Devices Table 59. Key Market Challenges & Risks of Transmucosal Drug Delivery Devices Table 60. Key Industry Trends of Transmucosal Drug Delivery Devices Table 61. Transmucosal Drug Delivery Devices Raw Material Table 62. Key Suppliers of Raw Materials Table 63. Transmucosal Drug Delivery Devices Distributors List Table 64. Transmucosal Drug Delivery Devices Customer List Table 65. Global Transmucosal Drug Delivery Devices Sales Forecast by Region (2024-2029) & (K Units) Table 66. Global Transmucosal Drug Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions) Table 67. Americas Transmucosal Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units) Table 68. Americas Transmucosal Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions) Table 69. APAC Transmucosal Drug Delivery Devices Sales Forecast by Region (2024-2029) & (K Units) Table 70. APAC Transmucosal Drug Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions) Table 71. Europe Transmucosal Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units) Table 72. Europe Transmucosal Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions) Table 73. Middle East & Africa Transmucosal Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units) Table 74. Middle East & Africa Transmucosal Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Global Transmucosal Drug Delivery Devices Sales Forecast by Type (2024-2029) & (K Units) Table 76. Global Transmucosal Drug Delivery Devices Revenue Forecast by Type (2024-2029) & ($ Millions) Table 77. Global Transmucosal Drug Delivery Devices Sales Forecast by Application (2024-2029) & (K Units) Table 78. Global Transmucosal Drug Delivery Devices Revenue Forecast by Application (2024-2029) & ($ Millions) Table 79. Allergan Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 80. Allergan Transmucosal Drug Delivery Devices Product Portfolios and Specifications Table 81. Allergan Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 82. Allergan Main Business Table 83. Allergan Latest Developments Table 84. Amphastar Pharmaceuticals Inc Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 85. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product Portfolios and Specifications Table 86. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 87. Amphastar Pharmaceuticals Inc Main Business Table 88. Amphastar Pharmaceuticals Inc Latest Developments Table 89. Aquestive Therapeutics Inc Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 90. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product Portfolios and Specifications Table 91. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 92. Aquestive Therapeutics Inc Main Business Table 93. Aquestive Therapeutics Inc Latest Developments Table 94. ARS Pharmaceuticals Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 95. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product Portfolios and Specifications Table 96. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 97. ARS Pharmaceuticals Main Business Table 98. ARS Pharmaceuticals Latest Developments Table 99. Combinent BioMedical Systems Inc Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 100. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product Portfolios and Specifications Table 101. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 102. Combinent BioMedical Systems Inc Main Business Table 103. Combinent BioMedical Systems Inc Latest Developments Table 104. Aegis Therapeutics LLC Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 105. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product Portfolios and Specifications Table 106. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 107. Aegis Therapeutics LLC Main Business Table 108. Aegis Therapeutics LLC Latest Developments Table 109. Bespak Europe Ltd Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 110. Bespak Europe Ltd Transmucosal Drug Delivery Devices Product Portfolios and Specifications Table 111. Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 112. Bespak Europe Ltd Main Business Table 113. Bespak Europe Ltd Latest Developments Table 114. Callitas Therapeutics Inc Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 115. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product Portfolios and Specifications Table 116. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 117. Callitas Therapeutics Inc Main Business Table 118. Callitas Therapeutics Inc Latest Developments List of Figures Figure 1. Picture of Transmucosal Drug Delivery Devices Figure 2. Transmucosal Drug Delivery Devices Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Transmucosal Drug Delivery Devices Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Transmucosal Drug Delivery Devices Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Transmucosal Drug Delivery Devices Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Buccal Route Figure 10. Product Picture of Rectal Route Figure 11. Product Picture of Nasal Route Figure 12. Global Transmucosal Drug Delivery Devices Sales Market Share by Type in 2022 Figure 13. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2018-2023) Figure 14. Transmucosal Drug Delivery Devices Consumed in Hospital Figure 15. Global Transmucosal Drug Delivery Devices Market: Hospital (2018-2023) & (K Units) Figure 16. Transmucosal Drug Delivery Devices Consumed in Residential Figure 17. Global Transmucosal Drug Delivery Devices Market: Residential (2018-2023) & (K Units) Figure 18. Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2022) Figure 19. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application in 2022 Figure 20. Transmucosal Drug Delivery Devices Sales Market by Company in 2022 (K Units) Figure 21. Global Transmucosal Drug Delivery Devices Sales Market Share by Company in 2022 Figure 22. Transmucosal Drug Delivery Devices Revenue Market by Company in 2022 ($ Million) Figure 23. Global Transmucosal Drug Delivery Devices Revenue Market Share by Company in 2022 Figure 24. Global Transmucosal Drug Delivery Devices Sales Market Share by Geographic Region (2018-2023) Figure 25. Global Transmucosal Drug Delivery Devices Revenue Market Share by Geographic Region in 2022 Figure 26. Americas Transmucosal Drug Delivery Devices Sales 2018-2023 (K Units) Figure 27. Americas Transmucosal Drug Delivery Devices Revenue 2018-2023 ($ Millions) Figure 28. APAC Transmucosal Drug Delivery Devices Sales 2018-2023 (K Units) Figure 29. APAC Transmucosal Drug Delivery Devices Revenue 2018-2023 ($ Millions) Figure 30. Europe Transmucosal Drug Delivery Devices Sales 2018-2023 (K Units) Figure 31. Europe Transmucosal Drug Delivery Devices Revenue 2018-2023 ($ Millions) Figure 32. Middle East & Africa Transmucosal Drug Delivery Devices Sales 2018-2023 (K Units) Figure 33. Middle East & Africa Transmucosal Drug Delivery Devices Revenue 2018-2023 ($ Millions) Figure 34. Americas Transmucosal Drug Delivery Devices Sales Market Share by Country in 2022 Figure 35. Americas Transmucosal Drug Delivery Devices Revenue Market Share by Country in 2022 Figure 36. Americas Transmucosal Drug Delivery Devices Sales Market Share by Type (2018-2023) Figure 37. Americas Transmucosal Drug Delivery Devices Sales Market Share by Application (2018-2023) Figure 38. United States Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 39. Canada Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 40. Mexico Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 41. Brazil Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 42. APAC Transmucosal Drug Delivery Devices Sales Market Share by Region in 2022 Figure 43. APAC Transmucosal Drug Delivery Devices Revenue Market Share by Regions in 2022 Figure 44. APAC Transmucosal Drug Delivery Devices Sales Market Share by Type (2018-2023) Figure 45. APAC Transmucosal Drug Delivery Devices Sales Market Share by Application (2018-2023) Figure 46. China Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 47. Japan Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 48. South Korea Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 49. Southeast Asia Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 50. India Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 51. Australia Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 52. China Taiwan Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 53. Europe Transmucosal Drug Delivery Devices Sales Market Share by Country in 2022 Figure 54. Europe Transmucosal Drug Delivery Devices Revenue Market Share by Country in 2022 Figure 55. Europe Transmucosal Drug Delivery Devices Sales Market Share by Type (2018-2023) Figure 56. Europe Transmucosal Drug Delivery Devices Sales Market Share by Application (2018-2023) Figure 57. Germany Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 58. France Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 59. UK Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 60. Italy Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 61. Russia Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 62. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Country in 2022 Figure 63. Middle East & Africa Transmucosal Drug Delivery Devices Revenue Market Share by Country in 2022 Figure 64. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Type (2018-2023) Figure 65. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Application (2018-2023) Figure 66. Egypt Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 67. South Africa Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 68. Israel Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 69. Turkey Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 70. GCC Country Transmucosal Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions) Figure 71. Manufacturing Cost Structure Analysis of Transmucosal Drug Delivery Devices in 2022 Figure 72. Manufacturing Process Analysis of Transmucosal Drug Delivery Devices Figure 73. Industry Chain Structure of Transmucosal Drug Delivery Devices Figure 74. Channels of Distribution Figure 75. Global Transmucosal Drug Delivery Devices Sales Market Forecast by Region (2024-2029) Figure 76. Global Transmucosal Drug Delivery Devices Revenue Market Share Forecast by Region (2024-2029) Figure 77. Global Transmucosal Drug Delivery Devices Sales Market Share Forecast by Type (2024-2029) Figure 78. Global Transmucosal Drug Delivery Devices Revenue Market Share Forecast by Type (2024-2029) Figure 79. Global Transmucosal Drug Delivery Devices Sales Market Share Forecast by Application (2024-2029) Figure 80. Global Transmucosal Drug Delivery Devices Revenue Market Share Forecast by Application (2024-2029)
Allergan Amphastar Pharmaceuticals Inc Aquestive Therapeutics Inc ARS Pharmaceuticals Combinent BioMedical Systems Inc Aegis Therapeutics LLC Bespak Europe Ltd Callitas Therapeutics Inc
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape